Valuation: DiaSorin S.p.A.

Market Cap 3.68B 4.21B 3.38B 3.15B 5.97B 401B 6.07B 40.66B 15.76B 197B 15.8B 15.46B 677B P/E 2026 *
20.2x
P/E 2027 * 17.6x
Enterprise Value 4.35B 4.98B 4B 3.73B 7.06B 474B 7.18B 48.11B 18.64B 233B 18.7B 18.29B 801B EV / Sales 2026 *
3.55x
EV / Sales 2027 * 3.23x
Free-Float
-
Yield 2026 *
1.89%
Yield 2027 * 1.96%
1 day-0.06%
1 week+1.46%
Current month+2.33%
1 month+3.09%
3 months+16.77%
6 months-0.43%
Current year+1.05%
1 week 67.54
Extreme 67.54
70.5
1 month 62.96
Extreme 62.96
75.3
Current year 52.34
Extreme 52.34
77.64
1 year 52.34
Extreme 52.34
92.32
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
208.8
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 2007-03-25
Director of Finance/CFO - 2024-12-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 2016-04-27
Director/Board Member 63 2007-03-25
Chairman 57 2022-04-28
Date Insider Type Main position Quantity % Market Cap.
03-23Buy

Chief Executive Officer

9,211 0.0165%
01-27Buy

Chief Executive Officer

7,500 0.0134%
01-07Buy

Director

1,000 0.0018%
Change 5-day change 1-year change 3-year change Capi.($)
-0.06%+1.46%-23.25%-25.92% 4.21B
-1.63%+17.52%+234.75%+369.22% 22.27B
-1.63%-2.53%-41.64%-25.79% 9.53B
+0.85%+0.81%+38.02%+30.95% 7.15B
-2.40%-2.14%-31.51% - 5.17B
+0.89%+3.80%-20.22%-25.08% 5.11B
-0.10%+9.18%+199.85%-30.14% 4.95B
-3.39%-6.50%+84.25%+90.74% 4.14B
+0.84%+1.86%-19.47%-41.72% 2.54B
-1.51%+8.51%-25.94%-10.63% 1.27B
Average -0.81%+4.74%+39.49%+36.85% 6.64B
Weighted average by Cap. -1.03%+7.58%+90.36%+131.89%

Financials

2026 *2027 *
Net sales 1.23B 1.4B 1.13B 1.05B 1.99B 134B 2.03B 13.56B 5.26B 65.56B 5.27B 5.16B 226B 1.31B 1.5B 1.2B 1.12B 2.12B 142B 2.16B 14.45B 5.6B 69.82B 5.61B 5.49B 241B
Net income 183M 209M 168M 156M 297M 19.91B 302M 2.02B 783M 9.76B 785M 768M 33.64B 206M 236M 189M 177M 335M 22.48B 341M 2.28B 884M 11.02B 886M 867M 37.99B
Net Debt 674M 771M 619M 577M 1.09B 73.44B 1.11B 7.45B 2.89B 36.02B 2.9B 2.83B 124B 543M 621M 499M 465M 882M 59.16B 896M 6B 2.33B 29.02B 2.33B 2.28B 99.99B
Logo DiaSorin S.p.A.
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2025, the group had 9 production sites located in Italy, the United States (4), Canada, Germany, the United Kingdom and Chine. Net sales are distributed geographically as follows: Italy (15.2%), Europe (24.9%), North America (51.8%), and other (8.1%).
Employees
3,242
Date Price Change Volume
26-07-03 69.34 -0.06% 61,288
26-07-02 €69.38 -0.54% 128,782
26-07-01 €69.76 +2.95% 212,969
26-06-30 €67.76 -3.14% 238,260
26-06-29 €69.96 +2.37% 331,777
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
69.38EUR
Average target price
70.52EUR
Spread / Average Target
+1.65%

Quarterly revenue - Rate of surprise